ZIC2 and ZIC3 promote SWI/SNF recruitment to safeguard progression towards human primed pluripotency
The primed epiblast acts as a transitional stage between the relatively homogeneous naïve epiblast and the gastrulating embryo. Its formation entails coordinated changes in regulatory circuits driven by transcription factors and epigenetic modifications. Using a multi-omic approach in human embryonic stem cell models across the spectrum of peri-implantation development, we demonstrate that the transcription factors ZIC2 and ZIC3 have overlapping but essential roles in opening primed-specific enhancers. Together, they are essential to facilitate progression to and maintain primed pluripotency. ZIC2/3 accomplish this by recruiting SWI/SNF to chromatin and loss of ZIC2/3 or degradation of SWI/SNF both prevent enhancer activation. Loss of ZIC2/3 also results in transcriptome changes consistent with perturbed Polycomb activity and a shift towards the expression of genes linked to differentiation towards the mesendoderm. Additionally, we find an intriguing dependency on the transcriptional machinery for sustained recruitment of ZIC2/3 over a subset of primed-hESC specific enhancers. Taken together, ZIC2 and ZIC3 regulate highly dynamic lineage-specific enhancers and collectively act as key regulators of human primed pluripotency.
Authors
- William A. Pastor (ORCID: https://orcid.org/0000-0003-4176-5299)
- Pierre Priam
- Laurence Côté (ORCID: https://orcid.org/0000-0002-3674-4218)
- Ishtiaque Hossain (ORCID: https://orcid.org/0000-0002-4494-0366)
- Sahil Sahni (ORCID: https://orcid.org/0009-0006-4678-3903)
- Julie A. Lessard (ORCID: https://orcid.org/0000-0003-3716-4618)
- Sofia C Reynoso (ORCID: https://orcid.org/0009-0005-7617-4124)
- Joelle Doumat
- Candus Chik
- Xiao X Zhang
- Tianxin Fu
Institutions
- McGill University Health Centre (CA)
- Institute for Research in Immunology and Cancer (CA)
- McGill University (CA)
- Université de Montréal (CA)
Publication Details
- Journal
- Nature Communications
- Published
- 2024-10-02
- DOI
- https://doi.org/10.1038/s41467-024-52431-1
- Citations
- 10
- Primary Topic
- Renal and related cancers
- Type
- article
- Field-Weighted Citation Impact
- 2.34
Funders
- Canadian Institutes of Health Research
- Natural Sciences and Engineering Research Council of Canada